Hyaluronic acid dermal filler Restylane Kysse has been approved by the US Food and Drug Administration (FDA) for lip augmentation and the correction of upper perioral rhytids.
A survey has indicated that only 22.5% of practitioners follow the recommended protocol for treating headaches with botulinum toxin.
The Advertising Standards Authority (ASA) has upheld a decision to ban a clinic’s marketing materials advertising injectable vitamin D and vitamin B12.
The Joint Council for Cosmetic Practitioners (JCCP) has published guidance on returning to work in aesthetic clinics.
The London Academy of Aesthetic Medicine has launched The Online Ultimate Toxin Course.
Skincare brand Radara is now available to be delivered to patients on behalf of clinics.
London-based aesthetic practitioner Dr Vincent Wong interviews Beijing-based Dr Hu Jin Tian on how his clinic is coping following the outbreak of coronavirus
A report from the Aesthetic Complications Expert Group annual conference
Aesthetic product manufacturer BioScience GmbH has launched Hyaprof, a new injectable line which combines monodensified and polydensified dermal fillers.
British Newspaper The Sun has teamed up with the government-approved register of accredited practitioners, Save Face, to launch the ‘Had Our Fill’ campaign against unregulated practitioners.